Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
All pharmaceutical manufacturers, including Novo Nordisk (NYSE:NVO) and Teva Pharmaceuticals, have agreed to participate in ...
The price negotiation process was established under former President Joe Biden's signature Inflation Reduction Act in 2022.
President Donald Trump's nominee to lead the agency overseeing Medicare should divest financial ties to healthcare and ...
Verywell Health on MSN5d
Novo Nordisk Offers Wegovy for $499 a Month in Direct-to-Consumer ProgramNovo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.
— Days after retaining the Nickles Group, Novo Nordisk also hired Checkmate Government Relations, the new D.C. outpost of a ...
Most HHS workers were emailed an offer to leave their job for as much as $25,000 as part of President Trump’s government cuts ...
Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...
Christopher Ridley, a spokesperson for Moderna, said the state legislative efforts are largely a product of ...
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback